Work with thought leaders and academic experts in genomics

Companies can benefit from working with Genomics experts in various ways. These experts can provide valuable insights and solutions for genetic research, drug discovery, personalized medicine, and more. They can help companies analyze and interpret genomic data, develop new diagnostic tools, and improve agricultural practices. Genomics experts can also contribute to the development of precision medicine and targeted therapies. Collaborating with these experts can lead to breakthrough discoveries, improved products, and competitive advantages in the market.

Researchers on NotedSource with backgrounds in genomics include Aayudh Das, Ph.D., R. Alan Harris, Ph.D., Katie Barr, Dr. Justin Whalley, Ph.D, Brittan S. Scales, M.P.H, Ph.D., Marie Mooney, PhD, Liam D. Hendrikse, Ph.D., Melisa Kozaczek, Ph.D., Ace Santiago, Ph.D., Asst. Prof. Eng. Davide Verzotto, Ph.D., Sumeet K. Tiwari, Alaa Ahmed, and Golya Shahrokhi.

Aayudh Das, Ph.D.

Boston, Massachusetts, United States of America
Scientist at Garuda therapeutics, specialized in Genomics and Computational Biology
Most Relevant Research Interests
Genomics
Other Research Interests (14)
Transcriptomics
Proteomics
Computational Biology
Metabolomics
Ecology, Evolution, Behavior and Systematics
And 9 more
About
I am a dedicated Scientist-I at Garuda Therapeutics, where I specialize in computational biology and genomics within the R&D department. My work primarily revolves around developing and optimizing pipelines for variant calling using Strelka2 and GATK4 with Whole Genome Sequencing (WGS) to identify oncogenes in human induced pluripotent stem cells (iPSCs). This involves extensive work in the qualification and validation of these pipelines for regulatory filings, as well as leveraging databases such as ClinVar, COSMIC, and DepMap to craft targeted oncogenes panels for deep sequencing. I also apply Next-Generation Sequencing (NGS) for downstream sequencing to validate CRISPR knockouts, including the identification and validation of CRISPR off-targets using techniques like rhAMPseq and Induce-seq. Additionally, my expertise extends to single-cell sequencing analysis and understanding structural variants with Optical Genome Mapping (Bionano). Prior to joining Garuda Therapeutics, I completed a postdoctoral fellowship in computational biology at Pennsylvania State University, where I honed my skills in identifying climate-adaptive variants and conducted Genome-Wide Association Studies (GWAS) to uncover resistance genes against parasites and other stressors. My academic journey began at the University of Vermont, where I explored abiotic stress resistance genes using transcriptomics and developed a robust understanding of RNA-seq data analysis, from assembly to gene annotation. My work is driven by a passion for leveraging computational and genomics tools to address pressing challenges in biology and healthcare, combining my rigorous academic training with a practical, solution-oriented approach to research and development.

See Full Profile

Dr. Justin Whalley, Ph.D

North Chicago, Illinois, United States of America
Assistant Professor of Bioinformatics, with experience in finding the quintessential features in large, multi-layered 'omic datasets.
Most Relevant Research Interests
Genomics
Other Research Interests (18)
Bioinformatics
Immunity
Tensor decomposition
Cancer
Cancer Research
And 13 more
About
Dr. Justin P. Whalley was educated in the UK (M.Sci. Mathematics, University of Bristol) and France (Ph.D. Bioinformatics, University of Évry). He moved to Spain to work as a postdoc at the National Center for Genomic Analysis (CNAG). During his time there, he ran the Quality Control working group for the Pan-Cancer Analysis of Whole Genomes project to assess the data coming in and reduce batch effects. This involved collaboration with researchers from the Broad Institute of MIT and Harvard, the German Cancer Research Center and the Wellcome Sanger Institute in the UK. He returned to the UK to work as a [Senior Bioinformatician at the University of Oxford](https://www.well.ox.ac.uk/people/jpw/). His time there coincided with the global pandemic and he was deeply involved in the COvid-19 Multi-omics Blood ATlas (COMBAT) consortium as the lead for the Integration (Tensor) working group. Dr. Whalley became a member of the [faculty of the Chicago Medical School at Rosalind Franklin University of Medicine and Science](https://www.rosalindfranklin.edu/academics/faculty/justin-p-whalley/) in January 2023.

See Full Profile

Brittan S. Scales, M.P.H, Ph.D.

Highly skilled Bioinformatician and Microbiologist trained in Microbiome and NGS research
Most Relevant Research Interests
genomics
Other Research Interests (19)
microbiomes
marine plastic biofilms
next-generation sequencing
bioinformatics
Microbiology (medical)
And 14 more
About
Dr. Brittan S. Scales is a highly educated and experienced microbiologist and immunologist with a passion for infectious diseases and public health. She received her Ph.D. in Microbiology and Immunology from the University of Michigan–Ann Arbor in 2015, where she focused on studying the interactions between the lung microbiome and immune response. She also obtained her Master of Public Health degree in Infectious Diseases and Vaccinology from the University of California, Berkeley, in 2009. After completing her Ph.D., Dr. Scales worked as a Postdoctoral Researcher at the University of Michigan's Department of Microbiology & Immunology and the Leibniz Institute for Baltic Sea Research in Germany. Her research during this time focused on understanding the role of microbes in the environment and their impact on human health. Most recently, Dr. Scales worked as a Ph.D. Production Expert at ScaleAI, where she utilized her expertise in coding, math, and science to develop software solutions for various industries. She also continues to conduct research and publish papers in the fields of microbiology and immunology. Dr. Scales is dedicated to using her knowledge and skills to contribute to the prevention and treatment of infectious diseases and promote public health. She is a highly sought-after expert in her field and is committed to making a positive impact in the scientific community and beyond.

See Full Profile

Example genomics projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on genomics?

Genomic Data Analysis for Drug Discovery

A pharmaceutical company can collaborate with a Genomics expert to analyze large-scale genomic data and identify potential drug targets. This collaboration can accelerate the drug discovery process and lead to the development of more effective and targeted therapies.

Development of Diagnostic Tools

A biotech company can work with a Genomics expert to develop innovative diagnostic tools based on genomic markers. These tools can enable early detection of diseases, improve patient outcomes, and revolutionize healthcare diagnostics.

Improving Agricultural Practices

An agricultural company can partner with a Genomics expert to optimize crop breeding programs using genomic selection. This collaboration can lead to the development of high-yielding and disease-resistant crops, improving agricultural productivity and sustainability.

Precision Medicine and Targeted Therapies

A healthcare company can collaborate with a Genomics expert to develop personalized medicine approaches based on individual genomic profiles. This collaboration can lead to the identification of targeted therapies, improving treatment outcomes and patient care.

Genomic Data Security and Privacy

A technology company can work with a Genomics expert to address the challenges of genomic data security and privacy. This collaboration can help develop robust encryption and privacy protocols, ensuring the safe storage and sharing of genomic data.